On July 10, 2026, Beneficient funded the closing of a primary capital transaction involving a $7.44 million net asset value investment fund interest. In exchange for the interest, a customer received 744,455 shares of Series B-11 Resettable Convertible Preferred Stock, which is convertible into Class A Common Stock at an initial conversion price of $3.6514 per share. Beneficient is a technology company providing software solutions for the financial services industry.